AJP - GI Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 275: G151-G158, 1998;
0193-1857/98 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuemmerle, J. F.
Right arrow Articles by Bushman, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuemmerle, J. F.
Right arrow Articles by Bushman, T. L.
Vol. 275, Issue 1, G151-G158, July 1998

IGF-I stimulates intestinal muscle cell growth by activating distinct PI 3-kinase and MAP kinase pathways

John F. Kuemmerle and Toni L. Bushman

Departments of Medicine and Physiology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia 23298-0711

Insulin-like growth factor I (IGF-I), acting via its cognate receptor, plays an autocrine role in the regulation of growth of intestinal muscle cells. In the present study the signaling pathways mediating the growth effects of IGF-I were characterized in cultured human intestinal smooth muscle cells. Growth induced by a maximally effective concentration of IGF-I (100 nM), measured as [3H]thymidine incorporation, was only partially inhibited by LY-294002 [phosphatidylinositol 3-kinase (PI 3-kinase) inhibitor] or PD-98059 [mitogen-activated protein (MAP) kinase kinase (MEK) inhibitor] (86 ± 7% and 35 ± 6% inhibition, respectively) alone but was abolished by the two combined (114 ± 18% inhibition), implying the participation of both pathways. IGF-I elicited time- and concentration-dependent increases in PI 3-kinase activity. This effect was inhibited only by LY-294002 (89 ± 12%). IGF-I elicited time- and concentration-dependent phosphorylation of p44/p42 MAP kinase and increased MAP kinase activity. These effects were inhibited only by PD-98059 (78 ± 9% and 98 ± 7%, respectively). We conclude that in human intestinal muscle cells IGF-I activates distinct PI 3-kinase and MAP kinase signaling pathways, which act in conjunction to mediate growth.

proliferation; p85; phosphatidylinositol 3,4,5-triphosphate; LY-294002; PD-98059


This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
K. B. Hazelgrove, R. S. Flynn, L.-Y. Qiao, J. R. Grider, and J. F. Kuemmerle
Endogenous IGF-I and {alpha}v{beta}3 integrin ligands regulate increased smooth muscle growth in TNBS-induced colitis
Am J Physiol Gastrointest Liver Physiol, June 1, 2009; 296(6): G1230 - G1237.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
L. Cheng, V. Pricolo, P. Biancani, and J. Behar
Overexpression of progesterone receptor B increases sensitivity of human colon muscle cells to progesterone
Am J Physiol Gastrointest Liver Physiol, September 1, 2008; 295(3): G493 - G502.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. G. Simmons, Y. Ling, H. Wilkins, C. R. Fuller, A. J. D'Ercole, J. Fagin, and P. K. Lund
Cell-specific effects of insulin receptor substrate-1 deficiency on normal and IGF-I-mediated colon growth
Am J Physiol Gastrointest Liver Physiol, November 1, 2007; 293(5): G995 - G1003.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. F. Kuemmerle
Occupation of {alpha}vbeta3-integrin by endogenous ligands modulates IGF-I receptor activation and proliferation of human intestinal smooth muscle
Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1194 - G1202.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. F. Kuemmerle
Endogenous IGF-I protects human intestinal smooth muscle cells from apoptosis by regulation of GSK-3{beta} activity
Am J Physiol Gastrointest Liver Physiol, January 1, 2005; 288(1): G101 - G110.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. F. Kuemmerle, K. S. Murthy, and J. G. Bowers
IGFBP-3 activates TGF-{beta} receptors and directly inhibits growth in human intestinal smooth muscle cells
Am J Physiol Gastrointest Liver Physiol, October 1, 2004; 287(4): G795 - G802.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
X. Xin, Y. T. Hou, L. Li, P. Schmiedlin-Ren, G. M. Christman, H.-L. Cheng, K. N. Bitar, and E. M. Zimmermann
IGF-I increases IGFBP-5 and collagen {alpha}1(I) mRNAs by the MAPK pathway in rat intestinal smooth muscle cells
Am J Physiol Gastrointest Liver Physiol, May 1, 2004; 286(5): G777 - G783.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. F. Kuemmerle, H. Zhou, and J. G. Bowers
IGF-I stimulates human intestinal smooth muscle cell growth by regulation of G1 phase cell cycle proteins
Am J Physiol Gastrointest Liver Physiol, March 1, 2004; 286(3): G412 - G419.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. F. Kuemmerle
IGF-I elicits growth of human intestinal smooth muscle cells by activation of PI3K, PDK-1, and p70S6 kinase
Am J Physiol Gastrointest Liver Physiol, March 1, 2003; 284(3): G411 - G422.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. F. Kuemmerle and B. Teng
Regulation of IGFBP-4 levels in human intestinal muscle by an IGF-I-activated, confluence-dependent protease
Am J Physiol Gastrointest Liver Physiol, November 1, 2000; 279(5): G975 - G982.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. F. Kuemmerle
Endogenous IGF-I regulates IGF binding protein production in human intestinal smooth muscle cells
Am J Physiol Gastrointest Liver Physiol, May 1, 2000; 278(5): G710 - G717.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online